Braslyn Ltd.

CIK 00016423556 companiesLYFORD CAY, NEW PROVIDENCE, C5

SEC Profile

Transactions

Companies

Filings

CIK

0001642355

Recent Transactions

50 trades

Disposition to Issuer
Mirati Therapeutics, Inc.
Common Stock
2024-01-23−3,201,440→ 0 total
Disposition to Issuer
Mirati Therapeutics, Inc.
Warrant (right to purchase)
2024-01-23−1,413,475→ 0 total
Disposition to Issuer
Mirati Therapeutics, Inc.
Warrant (right to purchase)
2024-01-23−332,809→ 0 total
Disposition to Issuer
Mirati Therapeutics, Inc.
Common Stock
2024-01-23−3,135,966→ 0 total
Disposition to Issuer
Mirati Therapeutics, Inc.
Warrant (right to purchase)
2024-01-23−3,578,036→ 0 total
Disposition to Issuer
Mirati Therapeutics, Inc.
Common Stock
2024-01-23−287,866→ 0 total
Disposition to Issuer
Mirati Therapeutics, Inc.
Common Stock
2024-01-23−203,754→ 0 total
Disposition to Issuer
Mirati Therapeutics, Inc.
Common Stock
2024-01-23−30,518→ 0 total
Sale
Mirati Therapeutics, Inc.
Common Stock
2021-03-10$195.52/sh−189→ 3,135,777 total
Sale
Mirati Therapeutics, Inc.
Common Stock
2021-03-10$196.12/sh−20→ 3,135,757 total
Sale
Mirati Therapeutics, Inc.
Common Stock
2021-03-10$198.00/sh−200→ 3,135,557 total
Exercise/Conversion
Mirati Therapeutics, Inc.
Common Stock
2021-03-10$0.00/sh+410→ 3,135,967 total
Sale
Mirati Therapeutics, Inc.
Common Stock
2021-03-10$195.90/sh−1→ 3,135,966 total
Sale
Mirati Therapeutics, Inc.
Common Stock
2021-03-09$197.30/sh−4,633→ 3,130,226 total
Sale
Mirati Therapeutics, Inc.
Common Stock
2021-03-09$197.81/sh−3,993→ 3,126,233 total
Exercise/Conversion
Mirati Therapeutics, Inc.
Common Stock
2021-03-09$0.00/sh+11,971→ 3,135,967 total
Sale
Mirati Therapeutics, Inc.
Common Stock
2021-03-09$195.82/sh−1,107→ 3,134,859 total
Sale
Mirati Therapeutics, Inc.
Common Stock
2021-03-09$199.08/sh−2,237→ 3,123,996 total
Sale
Mirati Therapeutics, Inc.
Common Stock
2021-03-09$191.00/sh−1→ 3,135,966 total
Sale
INSEEGO CORP.$INSG
Common Stock
2020-12-16$14.37/sh−293,848→ 7,614,830 total
Sale
INSEEGO CORP.$INSG
Common Stock
2020-12-15$14.81/sh−190,590→ 7,908,678 total
Sale
INSEEGO CORP.$INSG
Common Stock
2020-12-14$16.07/sh−178,949→ 8,099,268 total
Sale
INSEEGO CORP.$INSG
Common Stock
2020-12-14$15.62/sh−1,721,783→ 8,278,217 total
Sale
Mirati Therapeutics, Inc.
Common Stock
2020-10-29$206.50/sh−1,088→ 3,133,528 total
Sale
Mirati Therapeutics, Inc.
Common Stock
2020-10-29$208.78/sh−1,674→ 3,130,768 total
Sale
Mirati Therapeutics, Inc.
Common Stock
2020-10-29$210.58/sh−10,599→ 3,105,078 total
Sale
Mirati Therapeutics, Inc.
Common Stock
2020-10-29$214.31/sh−2,344→ 3,085,218 total
Sale
Mirati Therapeutics, Inc.
Common Stock
2020-10-29$207.96/sh−1,086→ 3,132,442 total
Sale
Mirati Therapeutics, Inc.
Common Stock
2020-10-29$209.66/sh−15,091→ 3,115,677 total
Sale
Mirati Therapeutics, Inc.
Common Stock
2020-10-29$211.50/sh−14,408→ 3,090,670 total
Sale
Mirati Therapeutics, Inc.
Common Stock
2020-10-29$218.85/sh−663→ 3,032,220 total
Sale
Mirati Therapeutics, Inc.
Common Stock
2020-10-29$220.02/sh−818→ 3,031,402 total
Exercise/Conversion
Mirati Therapeutics, Inc.
Warrant (right to purchase)
2020-10-29$5.60/sh−104,565→ 3,590,421 total
Sale
Mirati Therapeutics, Inc.
Common Stock
2020-10-29$203.32/sh−550→ 3,135,416 total
Sale
Mirati Therapeutics, Inc.
Common Stock
2020-10-29$212.66/sh−3,108→ 3,087,562 total
Sale
Mirati Therapeutics, Inc.
Common Stock
2020-10-29$217.14/sh−6,775→ 3,038,795 total
Sale
Mirati Therapeutics, Inc.
Common Stock
2020-10-29$205.64/sh−800→ 3,134,616 total
Sale
Mirati Therapeutics, Inc.
Common Stock
2020-10-29$215.08/sh−27,992→ 3,057,226 total
Sale
Mirati Therapeutics, Inc.
Common Stock
2020-10-29$216.06/sh−11,656→ 3,045,570 total
Sale
Mirati Therapeutics, Inc.
Common Stock
2020-10-29$218.04/sh−5,912→ 3,032,883 total
Exercise/Conversion
Mirati Therapeutics, Inc.
Common Stock
2020-10-29$0.00/sh+104,565→ 3,135,967 total
Tax Payment
Mirati Therapeutics, Inc.
Common Stock
2020-10-29$202.25/sh−1→ 3,135,966 total
Sale
Mirati Therapeutics, Inc.
Common Stock
2020-10-28$206.50/sh−41,266→ 2,965,302 total
Exercise/Conversion
Mirati Therapeutics, Inc.
Warrant (right to purchase)
2020-10-28$5.60/sh−295,438→ 3,694,986 total
Exercise/Conversion
Mirati Therapeutics, Inc.
Common Stock
2020-10-28$0.00/sh+295,438→ 3,135,968 total
Sale
Mirati Therapeutics, Inc.
Common Stock
2020-10-28$203.35/sh−44,959→ 3,091,007 total
Sale
Mirati Therapeutics, Inc.
Common Stock
2020-10-28$204.57/sh−38,543→ 3,052,464 total
Sale
Mirati Therapeutics, Inc.
Common Stock
2020-10-28$205.49/sh−45,896→ 3,006,568 total
Sale
Mirati Therapeutics, Inc.
Common Stock
2020-10-28$210.31/sh−23,283→ 2,841,030 total
Tax Payment
Mirati Therapeutics, Inc.
Common Stock
2020-10-28$209.16/sh−2→ 3,135,966 total

Companies

Recent Filings

Address

CAY HOUSE, EP TAYLOR DRIVE

LYFORD CAY, NEW PROVIDENCE, C5, N7776

View on SEC.gov